Publications by authors named "A Abelleira"
Background/importance: Opioids continue to play a key role in managing acute postoperative pain, but their use contributes to adverse outcomes. Buprenorphine may offer effective analgesia with a superior safety profile.
Objective: To compare the efficacy and safety of buprenorphine with other opioids for acute postoperative pain management in adults.
Aripiprazole has been linked to the development of impulse control problems (ICPs), most commonly gambling. Aripiprazole's effect on serotonergic and dopaminergic pathways has had mixed results on drinking behaviors. A male patient receiving outpatient psychiatric care presented with ongoing symptoms of depression on his current regimen of mirtazapine and gabapentin.
View Article and Find Full Text PDFGuidelines recommend strategies to optimize opioid medication safety, including frequent reassessment of the benefits and harms of long-term opioid therapy. Prescribers, who are predominantly primary care providers (PCPs), may lack the training or resources to implement these guideline-concordant practices. Two interventions have been designed to assist PCPs and tested within the Veterans Health Administration (VHA).
View Article and Find Full Text PDFArticle Synopsis
- - A new program called Video-Telecare Collaborative Pain Management (VCPM) was developed to help primary care providers manage chronic pain more effectively, especially during the challenges posed by the COVID-19 pandemic.
- - The study evaluated VCPM's feasibility and acceptability among veterans on long-term opioid therapy, with findings showing that participants appreciated the program, and many successfully switched to buprenorphine or reduced their opioid use.
- - Results indicated a significant decrease in patients' daily opioid dosage over three months, particularly for those attending multiple appointments, and the program met its initial goals, suggesting potential for further development in pain management strategies.
Background: Perioperative management of formulations of buprenorphine used for the treatment of opioid use disorder and/or pain are common clinical challenges. Care strategies are increasingly recommending continuation of buprenorphine while administering multimodal analgesia including full agonist opioids. While this "simultaneous strategy" is relatively simple for the shorter-acting sublingual buprenorphine formulation, best practices are needed for the increasingly prescribed extended-release buprenorphine (ER-buprenorphine).
View Article and Find Full Text PDF